Luminex EBITDA 2006-2018 | LMNX

Luminex ebitda from 2006 to 2018. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Luminex Annual EBITDA
(Millions of US $)
2018 $52
2017 $60
2016 $41
2015 $51
2014 $42
2013 $21
2012 $37
2011 $36
2010 $20
2009 $16
2008 $10
2007 $-3
2006 $6
2005 $-1
Luminex Quarterly EBITDA
(Millions of US $)
Q4 2018 $7
Q3 2018 $9
Q2 2018 $14
Q1 2018 $21
Q4 2017 $15
Q3 2017 $12
Q2 2017 $13
Q1 2017 $20
Q4 2016 $3
Q3 2016 $10
Q2 2016 $12
Q1 2016 $16
Q4 2015 $12
Q3 2015 $13
Q2 2015 $13
Q1 2015 $13
Q4 2014 $13
Q3 2014 $8
Q2 2014 $8
Q1 2014 $12
Q4 2013 $10
Q3 2013 $-0
Q2 2013 $9
Q1 2013 $2
Q4 2012 $11
Q3 2012 $7
Q2 2012 $10
Q1 2012 $9
Q4 2011 $7
Q3 2011 $6
Q2 2011 $11
Q1 2011 $11
Q4 2010 $7
Q3 2010 $2
Q2 2010 $4
Q1 2010 $6
Q4 2009 $2
Q3 2009 $4
Q2 2009 $7
Q1 2009 $4
Q4 2008 $4
Q3 2008 $5
Q2 2008 $1
Q1 2008 $0
Q4 2007 $8
Q3 2007 $-1
Q2 2007 $-10
Q1 2007 $0
Q4 2006 $6
Q3 2006 $-0
Q2 2006 $0
Q1 2006 $0
Q4 2005 $0
Q3 2005 $-1
Q2 2005 $-0
Q1 2005 $-0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.067B $0.316B
Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $105.261B 23.72
Intuitive Surgical (ISRG) United States $64.748B 60.48
Edwards Lifesciences (EW) United States $39.266B 40.21
Fresenius Medical Care AG KGaA (FMS) Germany $23.664B 16.20
IDEXX Laboratories (IDXX) United States $18.872B 51.39
ABIOMED (ABMD) United States $14.572B 96.19
Teleflex (TFX) United States $13.884B 30.44
Hologic (HOLX) United States $13.648B 20.64
Varian Medical Systems (VAR) United States $12.581B 31.43
DexCom (DXCM) United States $11.613B 444.93
STERIS (STE) United Kingdom $10.406B 26.74
Masimo (MASI) United States $7.109B 44.26
Penumbra (PEN) United States $5.474B 309.73
Integra LifeSciences Holdings (IART) United States $4.712B 22.85
Globus Medical (GMED) United States $4.682B 28.42
LivaNova (LIVN) United Kingdom $4.628B 28.53
Wright Medical Group (WMGI) Netherlands $3.980B 0.00
Tandem Diabetes Care (TNDM) United States $3.969B 0.00
Glaukos (GKOS) United States $2.896B 0.00
Cantel Medical (CMD) United States $2.757B 27.42
Integer Holdings (ITGR) United States $2.736B 22.32
Inogen (INGN) United States $1.966B 39.18
AVANOS MEDICAL, INC (AVNS) United States $1.941B 21.08
Nevro (NVRO) United States $1.885B 0.00
OPKO Health (OPK) United States $1.557B 0.00
Pacific Biosciences Of California (PACB) United States $1.102B 0.00
Accelerate Diagnostics (AXDX) United States $1.083B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $1.059B 28.78
Tactile Systems Technology (TCMD) United States $1.045B 198.46
CryoLife (CRY) United States $1.043B 112.44
Veracyte (VCYT) United States $1.006B 0.00
Intersect ENT (XENT) United States $0.968B 0.00
Fluidigm (FLDM) United States $0.938B 0.00
Mesa Laboratories (MLAB) United States $0.875B 35.79
Natus Medical (BABY) United States $0.851B 17.75
AngioDynamics (ANGO) United States $0.811B 26.30
ViewRay (VRAY) United States $0.808B 0.00
AxoGen (AXGN) United States $0.795B 0.00
OrthoPediatrics (KIDS) United States $0.654B 0.00
Quotient (QTNT) Switzerland $0.556B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.462B 48.72
Si-Bone (SIBN) United States $0.440B 0.00
Accuray (ARAY) United States $0.414B 0.00
GenMark Diagnostics (GNMK) United States $0.412B 0.00
Pulse Biosciences (PLSE) United States $0.372B 0.00
RTI Surgical (RTIX) United States $0.357B 52.09
IRadimed (IRMD) United States $0.304B 64.19
SeaSpine Holdings (SPNE) United States $0.282B 0.00
Sientra (SIEN) United States $0.276B 0.00
Neuronetics (STIM) United States $0.262B 0.00
Nuvectra (NVTR) United States $0.206B 0.00
ConforMIS (CFMS) United States $0.162B 0.00
Helius Medical Technologies (HSDT) United States $0.159B 0.00
Ekso Bionics Holdings (EKSO) United States $0.153B 0.00
T2 Biosystems (TTOO) United States $0.129B 0.00
Biosig Technologies (BSGM) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.121B 0.00
SOLITON INC (SOLY) $0.114B 0.00
Alphatec Holdings (ATEC) United States $0.114B 0.00
Second Sight Medical Products (EYES) United States $0.106B 0.00
Vermillion (VRML) United States $0.103B 0.00
Apollo Endosurgery (APEN) United States $0.088B 0.00
EDAP TMS (EDAP) France $0.085B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.073B 0.00
Titan Medical (TMDI) Canada $0.065B 0.00
Ra Medical Systems (RMED) United States $0.050B 0.00
Viveve Medical (VIVE) United States $0.044B 0.00
Avinger (AVGR) United States $0.037B 0.00
OBALON THERPTCS (OBLN) United States $0.037B 0.00
Microbot Medical (MBOT) United States $0.034B 0.00
PAVmed (PAVM) United States $0.028B 0.00
DarioHealth (DRIO) Israel $0.027B 0.00
Restoration Robotics (HAIR) United States $0.027B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
ENDRA Life Sciences (NDRA) United States $0.021B 0.00
Atossa Genetics (ATOS) United States $0.021B 0.00
Bioanalytical Systems (BASI) United States $0.021B 66.67
Dynatronics (DYNT) United States $0.017B 0.00
ReWalk Robotics (RWLK) Israel $0.016B 0.00
Nanovibronix (NAOV) United States $0.015B 0.00
Presbia (LENS) Ireland $0.012B 0.00
Neovasc (NVCN) Canada $0.012B 0.00
Allied Healthcare Products (AHPI) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00